These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6548423)

  • 41. [A method for chymotrypsin determination in the stool].
    Rose HJ; Baufeld W; Haude W
    Z Med Lab Diagn; 1981; 22(3):119-22. PubMed ID: 7293322
    [No Abstract]   [Full Text] [Related]  

  • 42. Determination of proteolytic enzymes by flow-injection analysis.
    Nicholas P; Lamy A; Reymond S
    Anal Biochem; 1991 Jan; 192(1):70-3. PubMed ID: 2048737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical value of a new fecal elastase test for detection of chronic pancreatitis.
    Keim V; Teich N; Moessner J
    Clin Lab; 2003; 49(5-6):209-15. PubMed ID: 15285176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A general kinetic approach to investigation of active-site availability in macromolecular catalysts.
    Resmini M; Gul S; Carter S; Sonkaria S; Topham CM; Gallacher G; Brocklehurst K
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):117-25. PubMed ID: 10657247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conformationally changed cytochrome c-mediated fusion of enzyme- and substrate-containing liposomes.
    Yoshimoto M; Walde P; Umakoshi H; Kuboi R
    Biotechnol Prog; 1999; 15(4):689-96. PubMed ID: 10441360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Determination of chymotrypsin in feces as screening method for exocrine pancreatic insufficiency].
    Bode JC; Dürr HK
    Dtsch Med Wochenschr; 1977 Feb; 102(5):165-6. PubMed ID: 832603
    [No Abstract]   [Full Text] [Related]  

  • 47. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnostic value of stool-chymotrypsin determination in the diagnosis of exocrine pancreatic insufficiency (author's transl)].
    Schneider R; Dürr HK; Bode JC
    Dtsch Med Wochenschr; 1974 Jul; 99(27):1449-54. PubMed ID: 4843502
    [No Abstract]   [Full Text] [Related]  

  • 49. Human pancreatic enzymes. Isolation and properties of a major form of chymotrypsin.
    Coan MH; Roberts RC; Travis J
    Biochemistry; 1971 Jul; 10(14):2711-7. PubMed ID: 4997645
    [No Abstract]   [Full Text] [Related]  

  • 50. [Analysis of pancreatic function. Determination of fecal chymotrypsin and the secretin-pancreozymin test. Comparative study].
    Tympner F; Reiner T; Domschke W
    Fortschr Med; 1977 Jul; 95(27):1711-4. PubMed ID: 903053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Controlled study on the diagnostic value of fecal chymotrypsin determination].
    Dürr HK; Otte M; Forell MM; Bode JC
    Verh Dtsch Ges Inn Med; 1974; 80():546-8. PubMed ID: 4454617
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fecal chymotrypsin test in the diagnosis of pancreatic insufficiency].
    Lami F; Callegari C; Nieddu A; Miglioli M; Barbara L
    Recenti Prog Med; 1985 Feb; 76(2):95-9. PubMed ID: 3873092
    [No Abstract]   [Full Text] [Related]  

  • 53. Optimized determination of angiotensin I-converting enzyme activity with hippuryl-L-histidyl-L-leucine as substrate.
    Schnaith E; Beyrau R; Bückner B; Klein RM; Rick W
    Clin Chim Acta; 1994 Jun; 227(1-2):145-58. PubMed ID: 7955411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fecal elastase-1 as a test for pancreatic function: a review.
    Dominici R; Franzini C
    Clin Chem Lab Med; 2002 Apr; 40(4):325-32. PubMed ID: 12059069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Determination of fecal trypsin and chymotrypsin as screening method for exocrine pancreas insufficiency].
    Schneider R; Dürr HK; Bode JC
    Verh Dtsch Ges Inn Med; 1973; 79():859-61. PubMed ID: 4790024
    [No Abstract]   [Full Text] [Related]  

  • 56. A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915).
    Asai K; Asai M
    Clin Chim Acta; 1984 Dec; 144(2-3):163-71. PubMed ID: 6397281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and characterization of an automated assay of effective heparin activity in plasma.
    Pierson-Perry JF; Obzansky DM; Mizzer JP
    Clin Chem; 1987 Sep; 33(9):1630-4. PubMed ID: 3621562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 5. Stool enzyme measurements.
    Boyd EJ; Wormsley KG
    Int J Pancreatol; 1988 Mar; 3(2-3):101-3. PubMed ID: 3283264
    [No Abstract]   [Full Text] [Related]  

  • 59. [Diagnostic value of fecal chymotrypsin determination in pancreatic diseases].
    Hayakawa T; Noda A; Kondo T; Shibata T; Murase T; Sugimoto Y; Ogawa Y; Suzuki T; Okumura N; Nagai K
    Nihon Shokakibyo Gakkai Zasshi; 1985 Dec; 82(12):2973-8. PubMed ID: 3831449
    [No Abstract]   [Full Text] [Related]  

  • 60. A spectrophotometric and automated method for the determination ot trypsin and chymotrypsin in the duodenal contents.
    Berndt W
    Z Klin Chem Klin Biochem; 1974 May; 12(5):237. PubMed ID: 4440133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.